Aerovate Therapeutics, Inc. (AVTE) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts AVTE Hot Sheet
Join SI Premium – FREE
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) reported Q2 EPS of ($0.76), $0.06 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Aerovate Therapeutics, Inc. (AVTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
